Christian Angermayer
Billionaire Founder of Apeiron Investment Group
Founder of Apeiron Investment Group and a prominent investor, Christian Angermayer joined us to discuss the cutting-edge areas that are shaping the future of health, technology, and finance. Known for driving the modern psychedelics renaissance, Angermayer co-founded ATAI Life Sciences, a biopharmaceutical company focused on developing psychedelic compounds like psilocybin and ketamine for mental health treatments. ATAI went public on the Nasdaq in 2021, and the company is at the forefront of transforming mental healthcare through alternative therapies.
Angermayer's ventures extend beyond psychedelics. He is a leading advocate for longevity, having founded Rejuveron Life Sciences and Cambrian Biopharma, which work on therapies to extend human life and health spans. His interests also include brain-computer interfaces, where he supports innovations through Blackrock Neurotech, a company developing devices to help people with neurological conditions regain mobility and function. In the realm of finance, Angermayer has invested heavily in fintech, cryptocurrency, and AI, with projects like Northern Data, one of Europe's significant AI cloud platforms and Bitcoin miners.
#23 - Christian Angermayer - AI, Longevity & How To Re-Design Humanity For The Future?
You can listen to it by clicking on your favorite podcasting platform of choice.
Biography
Christian Angermayer grew up in Germany and started his entrepreneurial journey at a young age. He founded Apeiron Investment Group, which now manages over $3 billion and invests in sectors ranging from life sciences and tech to crypto and hospitality. His career highlights include co-founding Ribopharma, which later became part of Alnylam Pharmaceuticals, a major biotech firm. Angermayer's diverse portfolio reflects his vision of the "Next Human Agenda," where technology advances human capabilities and well-being.
Thought Leadership
Angermayer is a vocal supporter of the medicalization of psychedelics, advocating for their use to address the global mental health crisis. His influence extends to policy and innovation forums, where he engages with global leaders to discuss scientific and technological advancements. He is also a film producer, with credits on movies like Army of Thieves and Hector and the Search for Happiness.
For more details on his work, you can explore his profile at - atai Life Sciences Milken Institute